Sorry, you need to enable JavaScript to visit this website.

Pipeline Discoveries for Autoimmune Diseases and Chronic Inflammation

Inflammation Immunology Drug Pipeline & Clinical Trials

Pfizer's mission is to deliver medicines that make a real difference in quality of life for patients with autoimmune diseases and chronic inflammation. Scientists in our research and development (R&D) programs are committed to speeding the delivery of new treatments. We pledge to maintain the safety of patients who take part in our trials and to uphold the highest ethical standards in all of our research initiatives.

On this page, you will find more information about our pipeline, which investigational therapies are under development, and in which stages.

If you are a Health Care Professional and interested in further details (including pathways being explored, mechanisms of action of investigational compounds, and an overall summary of investigational compounds organized by therapy area and disease state), please visit our in-depth Pfizer Immunology & Inflammation Research Pipeline site.

Immunology Pipeline as of May 1, 2024
  • 00 Phase 1
  • 00 Phase 2
  • 00 Phase 3
  • 00 Registration
  • 00 Total

Inflammation Immunology Pipeline & Trials